scispace - formally typeset
M

María Gabriela Ortega

Researcher at National University of Cordoba

Publications -  39
Citations -  729

María Gabriela Ortega is an academic researcher from National University of Cordoba. The author has contributed to research in topics: Dalea & Superoxide dismutase. The author has an hindex of 16, co-authored 37 publications receiving 600 citations. Previous affiliations of María Gabriela Ortega include National Scientific and Technical Research Council.

Papers
More filters
Journal ArticleDOI

Anticholinesterase activity in an alkaloid extract of Huperzia saururus

TL;DR: The anticholinesterase activity in vitro of the alkaloid extract is studied using erythrocyte membranes and human serum as sources of acetylcholines terase and pseudocholinestersterase, showing a selectivity of the extract for the true acetylCholinesTERase.
Journal ArticleDOI

Investigation of the in vitro and ex vivo acetylcholinesterase and antioxidant activities of traditionally used Lycopodium species from South America on alkaloid extracts.

TL;DR: This study showed that the biological properties of the folk medicinal plants LyCopodium clavatum and Lycopodium thyoides include AChE inhibitory activity and antioxidant effects, two possible mechanisms of action in Alzheimer's related processes.
Journal ArticleDOI

Antifungal activity of a prenylated flavonoid from Dalea elegans against Candida albicans biofilms.

TL;DR: The data suggest that 8PP may be useful for the treatment of biofilm-related Candida infections, through an accumulation of endogenous ROS and RNI that can induce an adaptive response based on a coordinated increase in antioxidant defenses.
Journal ArticleDOI

Xanthine oxidase inhibitory activity of natural and hemisynthetic flavonoids from Gardenia oudiepe (Rubiaceae) in vitro and molecular docking studies.

TL;DR: A series of polymethoxyflavones isolated and hemisynthesized from the bud exudates of Gardenia oudiepe has been evaluated for in-vitro XO inhibitory activity and promising results are suggested, suggest the use of these compounds as potential leads for the design and development of novel XO inhibitors.